About
Kodiak Sciences Inc — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences
Mar 31 2026
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Mar 26 2026
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
Feb 4 2026
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
Jan 7 2026
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
Recent Videos

KOD STOCK : STRONG RECOVERY | KODIAK SCIENCES STOCK
Apr 27, 2026

SpicyTrade Kodiak Sciences Inc ( $KOD ) daily stock analysis
Apr 20, 2026

KOD, Kodiak Sciences Inc., 2026-04-17, stock prices dynamics, stock of the day
Apr 19, 2026

Kodiak Sciences ABC Platform | The Retinal Market Takeover
Apr 16, 2026
Translate